Community acquired pneumonia (CAP) and PSI mortality risk stratification

C. N. Meyer, S. Novovic (Copenhagen, Denmark)

Source: Annual Congress 2004 - Community acquired and nosocomial pneumonia
Session: Community acquired and nosocomial pneumonia
Session type: Thematic Poster Session
Number: 2547
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. N. Meyer, S. Novovic (Copenhagen, Denmark). Community acquired pneumonia (CAP) and PSI mortality risk stratification. Eur Respir J 2004; 24: Suppl. 48, 2547

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community acquired pneumonia (CAP) mortality and biomarkers
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Community acquired pneumonia (CAP). Mortality prediction using the BTS-rule
Source: Eur Respir J 2004; 24: Suppl. 48, 413s
Year: 2004

Community acquired pneumonia (CAP) 30 days mortality and biomarkers
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010

Factors influencing in-hospital mortality in community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006

Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Assessment of prognostic scores for 30-day mortality prediction in hospitalised patients with health care associated pneumonia (HCAP)
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010

Mortality and prognostic factors of necrotizing community acquired pneumonia (NCAP) in a general hospital
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

Validation of a computer predictive model to stratify risk and site of care in community acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Health care associated pneumonia (HCAP) and community acquired pneumonia (CAP): Are they different diseases?
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010

In-hospital mortality risk assessment in patients with community acquired pneumonia
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007

COPD is an independent risk factor for mortality in community acquired pneumonia
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003

Comparison of prospective scores for predicting mortality and hospital admission in hospitalised patients and out-patients with CAP
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Risk factors for ICU acquired pneumonia
Source: Annual Congress 2008 - Acute lung injury and weaning
Year: 2008

3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
Source: Eur Respir J 2016; 47:1572-1574
Year: 2016


Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005

Biomarkers and community acquired pneumonia (CAP) severity
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Biomarkers and community acquired pneumonia (CAP) severity
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010

Risk factors of treatment failure of community acquired pneumonia in patients with COPD
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008